Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice
Tumori Journal ( IF 1.9 ) Pub Date : 2022-09-15 , DOI: 10.1177/03008916221122554 Raffaella D'Onofrio 1 , Francesco Caputo 1 , Francesco Prampolini 2 , Andrea Spallanzani 1 , Fabio Gelsomino 1 , Stefania Bettelli 3 , Samantha Manfredini 3 , Luca Reggiani Bonetti 4 , Pietro Carotenuto 5, 6 , Alessandro Bocconi 1 , Massimo Dominici 1 , Gabriele Luppi 1 , Massimiliano Salati 1, 7
Tumori Journal ( IF 1.9 ) Pub Date : 2022-09-15 , DOI: 10.1177/03008916221122554 Raffaella D'Onofrio 1 , Francesco Caputo 1 , Francesco Prampolini 2 , Andrea Spallanzani 1 , Fabio Gelsomino 1 , Stefania Bettelli 3 , Samantha Manfredini 3 , Luca Reggiani Bonetti 4 , Pietro Carotenuto 5, 6 , Alessandro Bocconi 1 , Massimo Dominici 1 , Gabriele Luppi 1 , Massimiliano Salati 1, 7
Affiliation
Aim:To apply extended ctDNA-based RAS genotyping to clinical criteria for improving the selection of patients eligible for anti-EGFR-based rechallenge in a real-world setting.Methods:ctDNA testing ...
中文翻译：
CtDNA 引导的 RASwt 转移性结直肠癌再次抗 EGFR 治疗：来自临床实践的证据
目的：将基于 ctDNA 的扩展 RAS 基因分型应用于临床标准，以改善在现实环境中适合接受基于抗 EGFR 的再挑战的患者的选择。方法：ctDNA 测试...
更新日期：2022-09-15
中文翻译：
CtDNA 引导的 RASwt 转移性结直肠癌再次抗 EGFR 治疗：来自临床实践的证据
目的：将基于 ctDNA 的扩展 RAS 基因分型应用于临床标准，以改善在现实环境中适合接受基于抗 EGFR 的再挑战的患者的选择。方法：ctDNA 测试...
京公网安备 11010802027423号